CCL2 and Renal cyst: In this study, we demonstrated that the anti-inflammatory substance resveratrol reduced the production of monocyte chemotactic protein-1, complement factor B, and tumor necrosis factor-α (TNF-α) and reduced macrophage infiltration in cystic kidneys, delaying the progression of PKD by reducing inflammation in cystic kidneys (25).